SPOTLIGHT Events & Announcements
Web content is updated for consistency with 21st Century Cures Act!
Get Started with your submission:
The mission of the CDER Biomarker Qualification Program (BQP) is to work with external stakeholders to develop biomarkers as drug development tools. Qualified biomarkers have the potential to advance public health by encouraging efficiencies and innovation in drug development.
About FDA’s Biomarker Qualification Program
- Support outreach to stakeholders for the identification and development of new biomarkers
- Provide a framework for the review of biomarkers for use in regulatory decision-making
- Qualify biomarkers for specific contexts of use that address specified drug development needs
Contact us at: [email protected]